APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 21 analysts with an average price target of $33.69. This is a potential upside of $16.2 (92.62%) from yesterday's end of day stock price of $17.49.

Apellis Pharmaceuticals's activity chart (see below) currently has 204 price targets and 273 ratings on display. The stock rating distribution of APLS is 64.83% BUY and 35.17% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.49% with an average time for these price targets to be met of 185.96 days.

Highest price target for APLS is $83, Lowest price target is $21, average price target is $53.2.

Most recent stock forecast was given by LUCA ISSI from RBC on 21-Apr-2025. First documented stock forecast 04-Dec-2017.

Currently out of the existing stock ratings of APLS, 94 are a BUY (64.83%), 51 are a HOLD (35.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$21

$3.51 (20.07%)

$25

6 days ago
(21-Apr-2025)

5/6 (83.33%)

$2.97 (16.47%)

42

Hold

$31

$13.51 (77.24%)

$30

25 days ago
(02-Apr-2025)

2/3 (66.67%)

$8 (34.78%)

32

Buy

$54

$36.51 (208.75%)

$57

1 months 23 days ago
(04-Mar-2025)

12/21 (57.14%)

$28.85 (114.71%)

382

Hold

$29

$11.51 (65.81%)

$30

1 months 23 days ago
(04-Mar-2025)

16/20 (80%)

$3.85 (15.31%)

136

Hold

$32

$14.51 (82.96%)

$36

1 months 23 days ago
(04-Mar-2025)

1/10 (10%)

$6.85 (27.24%)

24

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 185.96 days on average for the stock forecasts to be realized with a an average price target met ratio 63.49

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse works at RAYMOND JAMES and has 5 price targets and 3 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Madhu Kumar with highest potential upside - $123.51

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Dae Gon Ha with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?